For example, peroxisome-proliferator-active receptor α (PPARα) and phosphoenolpyruvate carboxykinase 1 (PCK1), whose enzymatic activity are reduced in individuals with MASLD, are up-regulated significantly with adherence to an IF regimen [240]. Here, PCK1 is linked to metabolic dysfunction-associated steatotic liver disease.